BEONE MEDICINES LTD. (BEIGF) Free cash flow 2016–2025
BEONE MEDICINES LTD. (BEIGF) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$941.7MFY2025 · since FY2016: -$113.0M → $941.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $941.7M | +248.7% |
| FY2024 | -$633.3M | +63.2% |
| FY2023 | -$1.7B | +5.6% |
| FY2022 | -$1.8B | -16.7% |
| FY2021 | -$1.6B | -11.5% |
| FY2020 | -$1.4B | -66.8% |
| FY2019 | -$839.9M | -35.9% |
| FY2018 | -$618.0M | -1738.1% |
| FY2017 | -$33.6M | +70.2% |
| FY2016 | -$113.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice